Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

European Science Foundation Sets Out Research Strategy ...

21.06.2006
... to Push Rheumatic Diseases up the Health Agenda and Speed Development of New Therapies

Europe's Experts in the Field Will Hear the Plan and Discuss the Recommendations at Their Annual Meeting in Amsterdam this Week.

The world's largest meeting of experts in rheumatic diseases will today hear and debate calls for a pan-European approach to prioritise and combine the efforts of many excellent scientific and clinical groups working at a national level, and accelerate research in the field.

The European League Against Rheumatism (EULAR) meeting in Amsterdam will be briefed on the findings of an expert group on rheumatic diseases, established by the ESF to set out research priorities for Europe, to improve treatments and prevent disease.

Stiff and aching joints may be accepted as an inevitable aspect of ageing, but the fact is that rheumatism is the leading cause of pain and disability in Europe, with approximately 100 million sufferers. Joint diseases account for half of all chronic conditions in over 65-year olds, a figure that will rise as the population ages.

And while these diseases are mainly afflictions of age, there is significant unmet medical need in paediatric rheumatism.

The cost of treatments and the economic loss caused by rheumatic diseases is estimated to more than Euros 200 billions per year.

The task force, comprising Europe's leading researchers and clinicians, along with observers from a patients' representative group and the European Medicines Agency, EMEA, has looked across the field, considering all aspects of basic research and clinical practice, and distilled its findings into five key recommendations. The aim is to provide coherent objectives for national and European funding bodies and healthcare providers, and ensure that rheumatic diseases are acknowledged as a major group of diseases within the European Commission Framework Programme 7.

Bertil Andersson, ESF Chief Executive said, "The ambition in this policy paper lies not only in identifying key issues in epidemiology, basic, translational and public health research in rheumatic diseases, but also in presenting the considered and balanced view of experts from across the field on what the research priorities should be."

The following recommendations are made:

The ESF and EULAR want scientists meeting in Amsterdam this week to discuss and question these recommendations, enabling them to be refined and presented as representing the views of all Europe's experts in rheumatic diseases.

Professor Maxime Dougados of Groupe Hospitalier Cochin, Paris, co-chair of the task force group said, "Excellent research is being carried out in countries across Europe. We need to create bridges to allow data be pooled so we can compare or merge different cohorts. This will help us to assess the burden of disease, understand the predisposing factors and find biomarkers for diagnosing and monitoring disease."

"At the same time we need a strong relationship between EMEA and rheumatologists, to allow patients' needs to be considered in the drug approval process, and to ensure the regulator gets consistent, independent and expert advice."

Co-chair, Professor Andreas Radbruch of DRFZ, Berlin, said, "The great challenge in rheumatology today is to apply the growing understanding of the underlying molecular mechanisms - both in terms of how disease is initiated and propagated, and the cellular processes involved in degeneration and regeneration of the affected tissues - to develop disease-modifying and regenerative therapies."

"Across Europe, there is considerable competence in the field of rheumatology, but it will require significant pan-European coordination and funding of integrated research to achieve this goal."

Contacts:
Dr Carole Moquin-Pattey
cmoquin-patttey@esf.org
Professor Maxime Dougados
maxime.dougados@cch.ap-hop-paris.fr
Professor Andreas Radbruch
radbruch@drfz.de

Dr Carole Moquin-Pattey | presseportal
Further information:
http://www.esf.org

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>